Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer
Conditions: Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Nonmalignant Neoplasm; Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol SpecificInterventions: Biological: anti-thymocyte globulin; Drug: busulfan; Drug: carboplatin; Drug: cyclophosphamide; Drug: etoposide; Drug: fludarabine phosphate; Drug: melphalan; Drug: thiotepa; Radiation: total-body irradiationSponsor: Roswell Park Cancer InstituteActive, not recruiting - verified October 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Anemia | Aplastic Anemia | Cancer | Cancer & Oncology | Chemotherapy | Chronic Myeloproliferative Neoplasm | Hematology | Leukemia | Lymphoma | Research | Stem Cell Therapy | Stem Cells | Transplants